Many emerging infectious diseases are caused by generalist pathogens that infect and
transmit via multiple host species with multiple dissemination routes, thus confounding the …

Critical knowledge gaps regarding infection with Mycobacterium ulcerans, the cause of
Buruli ulcer (BU), have impeded development of new therapeutic approaches and vaccines …

Buruli ulcer (BU), a neglected tropical disease of the skin, caused by Mycobacterium
ulcerans, occurs most frequently in children in West Africa. Risk factors for BU include …

Mycobacterium ulcerans is recognised as the third most common mycobacterial infection
worldwide. It causes necrotising infections of skin and soft tissue and is classified as a …

Background Mycobacterium ulcerans (MU) is the agent responsible for Buruli Ulcer (BU), an
emerging skin disease with dramatic socioeconomic and health outcomes, especially in …

Pertussis remains an important cause of infant death worldwide and is an ongoing public
health concern even in countries with high vaccination coverage. A cross-sectional …

Background. Buruli ulcer (BU) is a necrotizing cutaneous infection caused by
Mycobacterium ulcerans. Early diagnosis is crucial to prevent morbid effects and misuse of …

The clinical presentation of Buruli ulcer (BU) is manifold and includes relatively unspecific,
non-ulcerative manifestations such as nodules, papules, plaques, and edema, which may …

Buruli ulcer (BU), caused by infection with Mycobacterium ulcerans, is a chronic necrotizing
human skin disease associated with the production of the cytotoxic macrolide exotoxin …

Buruli ulcer (BU) is a chronic necrotizing disease of the skin and subcutaneous fat tissue.
The causative agent, Mycobacterium ulcerans, produces mycolactone, a macrolide toxin …